Table 1 Baseline demographic and disease features characteristics in the two groups
From: Splenectomy before adult liver transplantation: a retrospective study
Variables | Before matching | P value | After matching | P value | ||
|---|---|---|---|---|---|---|
Sp + (n = 86) | Sp- (n = 734) | Sp + (n = 82) | Sp- (n = 82) | |||
Donor | ||||||
Age (mean ± SD, years) | 34.38 ± 9.46 | 33.58 ± 9.62 | 0.465 | 34.13 ± 9.39 | 34.94 ± 9.29 | 0.582 |
Male (%) | 72(83.3%) | 611(82.2%) | 0.910 | 69(84.1%) | 67(81.7%) | 0.836 |
height (mean ± SD, cm) | 166.62 ± 7.48 | 167.82 ± 6.69 | 0.121 | 166.67 ± 7.45 | 167.10 ± 6.21 | 0.689 |
weight (mean ± SD, kg) | 61.56 ± 6.45 | 63.52 ± 7.38 | 0.019 | 62.00 ± 6.29 | 62.10 ± 6.98 | 0.913 |
BMI (mean ± SD, kg/m2) | 22.14 ± 1.65 | 22.50 ± 2.05 | 0.117 | 22.28 ± 1.53 | 22.20 ± 1.85 | 0.779 |
Recipient | ||||||
Age (mean ± SD, years) | 46.34 ± 8.44 | 44.52 ± 9.90 | 0.102 | 46.32 ± 8.39 | 46.41 ± 9.64 | 0.945 |
Male (%) | 68(79.1%) | 619(84.3%) | 0.210 | 64(78.0%) | 67(81.7%) | 0.697 |
Height (mean ± SD, cm) | 166.90 ± 7.31 | 167.48 ± 6.43 | 0.428 | 166.856 ± 7.40 | 167.013 ± 7.06 | 0.889 |
Weight (mean ± SD, kg) | 61.60 ± 9.55 | 63.42 ± 10.19 | 0.114 | 61.67 ± 9.49 | 61.15 ± 10.07 | 0.735 |
BMI (mean ± SD, kg/m2) | 22.08 ± 2.84 | 22.56 ± 3.03 | 0.161 | 22.11 ± 2.77 | 21.84 ± 2.81 | 0.547 |
HBV (%) | 66(76.7%) | 574(78.2%) | 0.757 | 62(75.6%) | 63(76.8%) | 0.854 |
TB (mean ± SD, μ mol/L) | 71.21 ± 98.22 | 145.73 ± 202.27 | 0.001 | 73.54 ± 100.01 | 83.45 ± 144.73 | 0.611 |
ALT (mean ± SD, u/L) | 41.54 ± 44.57 | 29.61 ± 27.63 | 0.089 | 36.61 ± 27.09 | 32.10 ± 22.32 | 0.363 |
AST (mean ± SD, u/L) | 33.04 ± 35.75 | 29.65 ± 32.98 | 0.520 | 31.81 ± 29.18 | 29.28 ± 17.80 | 0.588 |
Child-Pugh (mean ± SD) | 8.71 ± 1.80 | 8.46 ± 2.13 | 0.302 | 8.62 ± 1.76 | 8.53 ± 1.98 | 0.751 |
Child-Pugh <10 (A and B), n (%) | 60(69.77%) | 531(72.34%) | 0.614 | 58(70.73%) | 61(74.39%) | 0.600 |
MELD (mean ± SD) | 14.66 ± 6.66 | 17.54 ± 9.69 | 0.001 | 14.82 ± 6.88 | 14.57 ± 6.50 | 0.816 |
Serum AFP > 400 ng/mL (n, %) | 14(19.2%) | 141(16.3%) | 0.511 | 14(17.1%) | 15(18.3) | 0.838 |
Non-tumor (n,%) | 53(61.6%) | 416(56.7%) | 0.380 | 50(60.97) | 49(59.75) | 0.873 |
Number of tumor = 1 (n, %) | 27(31.4%) | 238(32.4%) | 0.395 | 27(32.9%) | 27(32.9%) | 1 |
Number of tumor = 2–3 (n,%) | 6(6.98%) | 80(10.9%) | 0.261 | 5(6.10%) | 6(7.32%) | 1 |
Tumor size < 3 cm (n, %) | 25(29.1%) | 193(26.3%) | 0.581 | 25(30.5%) | 26(31.7%) | 0.866 |
Tumor size > 3 cm (n, %) | 8(9.30%) | 125(17.0%) | 0.080 | 7(8.54%) | 6(7.32%) | 0.773 |
Tumor differentiation grade I, II (n, %) | 15(17.4%) | 140(19.1%) | 0.714 | 15(18.3%) | 14(17.1%) | 0.897 |
Tumor differentiation grade III (n, %) | 18(20.9%) | 178(24.3) | 0.494 | 17(20.7%) | 19(23.2%) | 0.706 |